Back to Journals » Clinical Ophthalmology » Volume 11

A protocol for topographic-guided corneal repair utilizing the US Food and Drug Administration-approved Wavelight Contoura

Authors Motwani M

Received 16 November 2016

Accepted for publication 28 February 2017

Published 23 March 2017 Volume 2017:11 Pages 573—581


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 6

Editor who approved publication: Dr Scott Fraser

Manoj Motwani

Motwani LASIK Institute, San Diego, CA, USA

Purpose: To demonstrate how Wavelight Contoura can be used to repair corneas damaged by trauma and prior poor surgical outcomes.
Methods: Four representative eyes are presented that show different scenarios in which highly irregular corneas can be corrected with Wavelight Contoura using a protocol (named the San Diego Protocol) designed to use the information in Contoura processing. Both laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) were used.
Results: Highly aberrant corneas with large amounts of warpage can be corrected safely with the Wavelight Contoura system. The San Diego Protocol requires individual analysis of each case with decisions based on the level of warpage and the level of epithelial hyperplastic compensation. The need for a second refractive power equalization procedure should be planned for.
Conclusion: Contoura measured refraction can be integrally used as part of the San Diego Protocol to safely repair highly warped corneas. The refractive outcomes show dramatic improvement in vision, best-corrected visual acuity (BCVA), refraction, and topographic uniformity.

Keywords: corneal ablation, laser-assisted in situ keratomileusis, photorefractive keratectomy, refractive surgery, corneal irregularity, corneal trauma, decentered excimer laser ablations, radial keratotomy, higher order aberrations

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]